Overlake Medical Center in Bellevue is the first in the state to offer the new MultiPoint Pacing technology, which offers more contact with the heart and in many cases is more effective than standard pacemakers.
The new technology called MPP for short is featured on the Quadra Assura MP cardiac resynchronization therapy defibrillators and used to treat heart failure.
MPP may also increase a heart failure patient’s response to CRT by increasing the amount of cardiac tissue being stimulated at one time, and may reduce the need for costly and invasive procedures to readjust the placement of the thin wires, called leads, around the heart.
Approximately 23 million people worldwide have congestive heart failure and 2 million new cases are diagnosed worldwide each year.
“We are very enthusiastic about being able to offer this new technology to our cardiac patients,” said Dr. Derek Rodrigues via a press release. He performed the procedure on a 65-year-old patient. “Because the leads on this pacemaker are in contact with more of the heart, it has potential to improve the heart’s ability to beat more naturally. In addition, MultiPoint Pacing technology essentially acts as a ‘personal trainer for the heart’, remodeling it to be healthier overall.”
“MultiPoint technology represents an important step forward in device efficacy for our heart failure patients,” said Carolyn Holmes, who manages the Invasive Cardiovascular Services team at Overlake. “State-of-the-art cardiac therapies improve our patient’s quality of life in such dramatic ways. It is gratifying to be at the vanguard of these new technologies.”
About Overlake Medical Center
Overlake Medical Center is the only non-profit, non-tax-supported, regional medical center with a network of medical clinics throughout the Eastside. It was the first Level III trauma service on the Eastside. For more information, visit online.